Abstract
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has made great strides since its inception to tackle the affliction of this vector-borne parasitic disease. National programmes have been working continuously to implement the main strategies to interrupt transmission with mass drug administration and to control morbidity in affected populations. Since 2000, more than 8·6 billion cumulative drug treatments have been delivered to more than 925 million people, the number of people infected has halved, and 17 of the 72 endemic countries have reached the elimination criteria and been validated by WHO.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
